NFIB and metastatic neoplasm: This mechanism has parallels with work in small-cell lung cancer showing altered chromatin landscapes in primary versus metastatic tumors due to genomic amplification of the NFIB, which encodes a TF that promotes neuroendocrine differentiation through chromatin pioneering activity (Denny et al., 2016, Yang et al., 2018).